Cargando…
CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
Although counteracting innate defenses allows oncolytic viruses (OVs) to better replicate and spread within tumors, CD8(+) T-cells restrict their capacity to trigger systemic anti-tumor immune responses. Herpes simplex virus-1 (HSV-1) evades CD8(+) T-cells by producing ICP47, which limits immune rec...
Autores principales: | Pourchet, Aldo, Fuhrmann, Steven R., Pilones, Karsten A., Demaria, Sandra, Frey, Alan B., Mulvey, Matthew, Mohr, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816761/ https://www.ncbi.nlm.nih.gov/pubmed/27077112 http://dx.doi.org/10.1016/j.ebiom.2016.01.022 |
Ejemplares similares
-
Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus
por: Burgess, Hannah M., et al.
Publicado: (2018) -
Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Pilones, Karsten A., et al.
Publicado: (2012) -
Mechanisms of synergy of radiotherapy and immunotherapy
por: Pilones, Karsten A, et al.
Publicado: (2015) -
Oncolytic Virus Immunotherapy
por: Marchini, Antonio, et al.
Publicado: (2021) -
Intratumoral IL-15 potentiates radiation-induced anti-tumor immunity
por: Pilones, Karsten, et al.
Publicado: (2015)